ORANGEBURG, N.Y., Jan. 24, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the third quarter of fiscal 2014, ended December 31, 2013, after the market closes on Monday, February 3, 2014. Howard Zauberman, President and Chief Executive Officer, and Keith Darragh, VP, Finance, will host a conference call to discuss the results as follows:
|Date:||Tuesday, February 4, 2014|
|Time:||8:30 a.m. EST|
|Conference dial-in:||(877) 303-1595 U.S.|
|(970) 315-0449 International|
An audio replay of the conference call will be available from 11:30 a.m. EST on Tuesday, February 4, 2014, through 11:59 p.m. EST on Tuesday, February 11, 2014, by dialing (855) 859-2056 from the U.S. or (404) 537-3406 from abroad. The audio webcast will also be available in the investor section of the Company's website, www.visionsciences.com.
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath® technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. Information about Vision-Sciences' products is available at www.visionsciences.com.
Vision-Sciences owns the trademarks Vision Sciences™ and Slide-On™ and the registered trademarks EndoSheath®, EndoWipe® and The Vision System®.